Top Markets
#1 Purr Purr +32.88%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +32.33%
#3 Siren Siren +30.36%
#4 OriginTrail OriginTrail +22.45%
#5 ApeX ApeX +19.17%
#6 UnifAI Network UnifAI Network +18.04%
#7 Unit Plasma Unit Plasma +17.45%
#8 Plasma Plasma +17.45%
#9 Wrapped XPL Wrapped XPL +17.45%
#10 Morpho Morpho +16.16%
Coin of the day
Purr Purr
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Cyteir Therapeutics, Inc. Cyteir Therapeutics, Inc.

Cyteir Therapeutics, Inc.

CYT
Clasificación en acciones #21570
Cyteir Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated... Cyteir Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to innovating and bringing to market cutting-edge precision oncology medicines. Its flagship compound, CYT-0851, is an novel, orally administered small molecule drug candidate, designed for once-daily dosing. This therapy is currently undergoing Phase I/II clinical evaluations, both as a standalone treatment and in combination with other drugs, targeting a broad range of solid tumors and hematologic malignancies. Furthermore, the company is advancing CYT-1853, another promising candidate in preclinical development for similar oncological indications. Cyteir Therapeutics was established in 2012 and is headquartered in Lexington, Massachusetts.
Precio por acción
$3.01
Última sincronización: 2024-04-12
Capitalización bursátil
$104.64M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Cyteir Therapeutics, Inc. (CYT)

Categoría

Healthcare
EPS de Cyteir Therapeutics, Inc. (CYT)
EPS a fecha de 2026 TTM: 0
Según los últimos informes financieros y el precio de las acciones de Cyteir Therapeutics, Inc., el EPS actual de la empresa (TTM) es 0. Al final del año 2026, la empresa tenía un EPS de 0 igual a al EPS de 2026, que fue de 0.
Historial de EPS de Cyteir Therapeutics, Inc. desde 2026 hasta 2026
EPS al final de cada año
Año EPS Cambiar
Not enough data for the provided dates.
EPS de empresas similares o competidoras
Empresa EPS Diferencia de EPS País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH